JH, F., A, S., V, S., J, P., D, W., ES, D., . . . R, V. (2021). Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children. Pediatric blood & cancer, 68(7), e29056. https://doi.org/10.1002/pbc.29056
Chicago Style (17th ed.) CitationJH, Foster, Sher A, Seghers V, Poston J, Wells D, Delpassand ES, Potter S, Mahajan P, and Venkatramani R. "Peptide Receptor Radionuclide Therapy for Treatment of Metastatic Neuroendocrine Tumors in Children." Pediatric Blood & Cancer 68, no. 7 (2021): e29056. https://doi.org/10.1002/pbc.29056.
MLA (9th ed.) CitationJH, Foster, et al. "Peptide Receptor Radionuclide Therapy for Treatment of Metastatic Neuroendocrine Tumors in Children." Pediatric Blood & Cancer, vol. 68, no. 7, 2021, p. e29056, https://doi.org/10.1002/pbc.29056.